Other Food and Drug Law Conferences

If you would like your conference listed on the FDLI conference website, email the FDLI marketing department.

Managing mHealth App Development Under FDA Regulation
"The MMA Roadshow"

FDA recently published its final guidance on mobile medical apps, and while helpful, the guidance leads to more questions. This workshop will focus on answering those questions for app developers in or close to FDA regulated territory.

We have selected some of the world’s leading engineering universities – in the US and in the EU – to be our partners in this program. We have sought out not only the best schools, but those located in population centers near where developers are working (programs take place from January - June).

We will dive deeply into the regulatory issues associated with bringing new mobile apps into the healthcare space.

January 16, 2014: University of Illinois at Chicago
January 23, 2014: Johns Hopkins University, Bloomberg School of Public Health
January 27, 2014: University of California San Diego
January 28, 2014: Stanford University
January 31, 2014: University of Texas at Austin

Remaining Dates:

March 20, 2014
Massachusetts Institute of Technology
MIT Media Lab - Multi Purpose Room
Building E14, 75 Amherst Street
Cambridge, MA 02139

May 6-8, 2014
mHealth Summit Europe
Berlin, Germany

June 12-13, 2014
HIMMS Innovation Center
1 St. Clair Avenue, NE
Cleveland, OH 44114


Quality & Donor Suitability Workshop 2014
Start Date: 3/10/2014
End Date: 3/13/2014

Registration will open December 2013

Kansas City Marriott Downtown
200 West 12th Street
Kansas City, MO 64105
(816) 421-6800

CLICK HERE for more information.


West Coast Pharmaceutical and Medical Device Conference

Hunton & Williams LLP invites you to participate in its upcoming complimentary conference taking place in San Diego, March 19-20. Day one of the two day event, focuses on emerging issues in pharmaceutical and medical device compliance and features keynote speaker Lauren Stevens, the former Vice President and Associate General Counsel, GlaxoSmithKline PLC. Ms. Stevens will share her personal account of being caught in the cross-hairs of a government investigation. Day two will cover pharmaceutical and medical device promotion and will feature a Q&A with former FDA Chief Counsel, and Hunton & Williams partner, Sheldon Bradshaw.

CLICK HERE for more information